AKI Risk	AKI Injury
Risk Factor	Beta Coefficient (SE)	Beta Coefficient (SE)
INTERCEPT	−4.13	−5.23
Demographics
Female	0.20	0.20
Age 36–45	0.01	0.12
Age 46–55	0.14	0.16
Age 56–65	0.24	0.12
Age >=66	0.35	0.30
Race (African American)	−0.03	0.07
Race (Other)	−0.05	0.36
Race (Unknown)	0.23	0.28
Medications
Amphotericin B	2.08	2.13
Cyclosporine	1.10	0.74
Loop Diuretics	0.73	0.81
Thiazide Diuretics	0.41	0.64
Aminoglycosides	0.43	0.40
NSAID	0.12	0.21
K-Sparing Diuretics	0.19	0.17
Acyclovir	−0.02	−0.41
Cisplatin	−0.48	−1.01
CT Scan w/ contrast	−0.08	−0.17
ARB	−0.04	−0.24
ACE	−0.22	−0.36
Clinical Condition Associations (Lab)
Bacterial Infection (Any Antibiotic Use)	0.56	1.04
Mean Admission Creatinine	−0.32	−0.62
Myocardial Infarction (Yes / Unknown)	0.10 / 0.10	0.37 / 0.10
Rhabdomyolysis (Yes / Unknown)	−0.02 / 0.01	−0.07 / −0.28
Acute Hepatitis (Yes / Unknown)	0.50 / 0.03	0.62 / −0.12
Acute Pancreatitis (Yes / Unknown)	−0.17 / −0.11	−0.20 / −0.15
Hyperammonemia	0.32 / −0.17	0.62 / 0.06
AST/ALT Ratio > 1.5	0.62 / 0.01	0.55 / −0.13
Thrombocytopenia	0.57 / −0.17	0.75 / 0.00
Leukocytosis	0.00 / −0.03	0.09 / 0.27
Hypercalcemia (corrected)	0.42 / 0.03	0.05 / 0.08
Mean Glucose >250 mg/dL	0.99	0.94
Mean Glucose 200–250 mg/dL	0.71	0.63
Mean Glucose 150–200 mg/dL	0.49	0.33
Mean Glucose Unknown	0.47	−0.17